相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Endocannabinoids inhibit release of nerve growth factor by inflammation-activated mast cells
Giuseppina Cantarella et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Autotaxin and LPA receptor signaling in cancer
Anna J. S. Houben et al.
CANCER AND METASTASIS REVIEWS (2011)
Aberrant Lipid Metabolism in Hepatocellular Carcinoma Revealed by Plasma Metabolomics and Lipid Profiling
Andrew D. Patterson et al.
CANCER RESEARCH (2011)
The Atypical Cannabinoid O-1602 Protects Against Experimental Colitis and Inhibits Neutrophil Recruitment
Rudolf Schicho et al.
INFLAMMATORY BOWEL DISEASES (2011)
Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor
Li Huang et al.
LABORATORY INVESTIGATION (2011)
Minireview: Recent Developments in the Physiology and Pathology of the Lysophosphatidylinositol-Sensitive Receptor GPR55
Christopher M. Henstridge et al.
MOLECULAR ENDOCRINOLOGY (2011)
G protein-coupled receptors: novel targets for drug discovery in cancer
Rosamaria Lappano et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK
C. Andradas et al.
ONCOGENE (2011)
The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation
R. Pineiro et al.
ONCOGENE (2011)
LPA Receptors: Subtypes and Biological Actions
Ji Woong Choi et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
A role for L-α-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells
Lesley A. Ford et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Lysophosphatidylinositol induces rapid phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 lymphoblastoid cells
Saori Oka et al.
JOURNAL OF BIOCHEMISTRY (2010)
Lysophosphatidic acid (LPA) receptors: Signaling properties and disease relevance
Mu-En Lin et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2010)
The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation
Christopher M. Henstridge et al.
FASEB JOURNAL (2009)
2-Arachidonoyl-sn-glycero-3-phosphoinositol: A Possible Natural Ligand for GPR55
Saori Oka et al.
JOURNAL OF BIOCHEMISTRY (2009)
Lipid G Protein-coupled Receptor Ligand Identification Using β-Arrestin PathHunter™ Assay
Hong Yin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Atypical Responsiveness of the Orphan Receptor GPR55 to Cannabinoid Ligands
Ankur Kapur et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Multi-stage chemical carcinogenesis in mouse skin: Fundamentals and applications
Erika L. Abel et al.
NATURE PROTOCOLS (2009)
The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo
Lauren S. Whyte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Gene expression Profiles of Lysophosphatidic Acid-Related Molecules in the Prostate: Relevance to Prostate Cancer and Benign Hyperplasia
Yu Zeng et al.
PROSTATE (2009)
The enigmatic pharmacology of GPR55
Ruth A. Ross
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain
Penny C. Staton et al.
PAIN (2008)
GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
Jane E. Lauckner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Activation of MAP kinase signaling through ERK5 but not ERK1 expression is associated with lymph node metastases in oral squamous cell carcinoma (OSCC)
Carsten Sticht et al.
NEOPLASIA (2008)
Identification of GPR55 as a lysophosphatidylinositol receptor
Saori Oka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
A role for endoglin as a suppressor of malignancy during mouse skin carcinogenesis
Eduardo Perez-Gomez et al.
CANCER RESEARCH (2007)
G-protein-coupled receptors and cancer
Robert T. Dorsam et al.
NATURE REVIEWS CANCER (2007)
Differential expression of lysophosphatidic acid receptor-2 in intestinal and diffuse type gastric cancer
H Yamashita et al.
JOURNAL OF SURGICAL ONCOLOGY (2006)
LPA2 receptor mediates mitogenic signals in human colon cancer cells
CC Yun et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2005)
Endocannabinoid metabolism in human glioblastomas and meningiomas compared to human non-tumour brain tissue
G Petersen et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer
D Shida et al.
LABORATORY INVESTIGATION (2004)
Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma
J Kitayama et al.
BREAST CANCER RESEARCH (2004)
Possible endocannabinoid control of colorectal cancer growth
A Ligresti et al.
GASTROENTEROLOGY (2003)
Anandamide and other N-acylethanolamines in human tumors
PC Schmid et al.
LIPIDS (2002)
Lysophosphatidic acid is a bioactive mediator in ovarian cancer
XJ Fang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2002)
Normal human pituitary gland and pituitary adenomas express cannabinoid receptor type 1 and synthesize endogenous cannabinoids:: First evidence for a direct role of cannabinoids on hormone modulation at the human pituitary level
U Pagotto et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: Comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids
YJ Xiao et al.
ANALYTICAL BIOCHEMISTRY (2001)
分享论文
